These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15000814)

  • 1. Detection of X chromosome aneuploidy using Southern blot analysis during routine population-based screening for fragile X syndrome.
    Adir V; Shahak E; Dar H; Borochowitz ZU
    Genet Test; 2003; 7(4):345-6. PubMed ID: 15000814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strategy for fragile-X carrier screening.
    Melis MA; Addis M; Lepiani C; Congeddu E; Cossu P; Cao A
    Genet Test; 1999; 3(3):301-4. PubMed ID: 10495931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic testing in fragile X syndrome].
    Sireteanu A; Rusu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and screening of fragile X syndrome: experiences in Taiwan.
    Lin SJ
    Acta Paediatr Taiwan; 2004; 45(2):67-8. PubMed ID: 15335112
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current aspects in the diagnosis of fragile X syndrome].
    Schorderet DF
    Rev Med Suisse Romande; 1992 May; 112(5):465-70. PubMed ID: 1351311
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis of fragile X syndrome].
    Glover G; Bernabé MJ; Carbonell P
    Rev Neurol; 2001 Oct; 33 Suppl 1():S6-9. PubMed ID: 12447811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of FMR1 trinucleotide repeat expansion mutations using Southern blot and PCR methodologies.
    Tarleton J
    Methods Mol Biol; 2003; 217():29-39. PubMed ID: 12491918
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small FRAXA premutations.
    Francis D; Burgess T; Mitchell J; Slater H
    Mol Diagn; 2000 Sep; 5(3):221-5. PubMed ID: 11070156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing.
    Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E
    Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel polymorphism in the FMR1 gene resulting in a "pseudodeletion" of FMR1 in a commonly used fragile X assay.
    Daly TM; Rafii A; Martin RA; Zehnbauer BA
    J Mol Diagn; 2000 Aug; 2(3):128-31. PubMed ID: 11229516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FMRP detection assay for the diagnosis of the fragile X syndrome.
    Willemsen R; Oostra BA
    Am J Med Genet; 2000; 97(3):183-8. PubMed ID: 11449486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and genetic aspects of fragile X mental retardation syndrome].
    Islamgulov DV; Karunas AS; Valinurov RG; Khusnutdinova EK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(8):69-74. PubMed ID: 16180508
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of Fragile X syndrome by Southern blot hybridization using a chemiluminescent probe: a laboratory protocol.
    Gold B; Radu D; Balanko A; Chiang CS
    Mol Diagn; 2000 Sep; 5(3):169-78. PubMed ID: 11070151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New methods for the diagnosis of fragile X syndrome: a study of the FMRP in blood and hair].
    Ramos-Fuentes FJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S9-S13. PubMed ID: 12447812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.
    Cronister A; DiMaio M; Mahoney MJ; Donnenfeld AE; Hallam S
    Genet Med; 2005 Apr; 7(4):246-50. PubMed ID: 15834242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A step-wise diagnosis of fragile X syndrome in Taiwan.
    Huang YT; Chiang SC; Tzeng CC; Liu CH; Chien YH; Hwu WL
    Acta Paediatr Taiwan; 2004; 45(2):69-72. PubMed ID: 15335113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound heterozygous female with fragile X syndrome.
    Linden MG; Tassone F; Gane LW; Hills JL; Hagerman RJ; Taylor AK
    Am J Med Genet; 1999 Apr; 83(4):318-21. PubMed ID: 10208169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-year experience demonstrates the utility of screening for both cytogenetic and FMR-1 abnormalities in patients with mental retardation.
    White BJ; Ayad M; Fraser A; Entwistle T; Winkler S; Sbeiti A; Fenwick R
    Genet Test; 1999; 3(3):291-6. PubMed ID: 10495929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.